Pathophysiology and management of cardiovascular disease in patients with HIV

Eric Nou1, Janet Lo1, Colleen Hadigan2

  • 1Program in Nutritional Metabolism, Massachusetts General Hospital, Boston, MA, USA.

Insights

People with HIV face higher cardiovascular disease risks due to traditional factors and immune activation. Modern antiretroviral therapy can minimize myocardial infarction risk by suppressing the virus and reducing inflammation.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Individuals with HIV exhibit elevated cardiovascular disease (CVD) risk, particularly coronary heart disease, compared to HIV-negative populations.
  • Increased prevalence of traditional CVD risk factors and persistent immune activation are noted in people living with HIV (PLWH).
  • Older antiretroviral therapy (ART) regimens were linked to higher CVD risk, likely due to metabolic side effects.

Purpose of the Study:

  • To examine the impact of modern antiretroviral therapy (ART) on cardiovascular disease risk in people with HIV (PLWH).
  • To understand the role of persistent immune activation in accelerated atherosclerosis despite ART.
  • To explore potential additional cardiovascular protection strategies for PLWH.

Main Methods:

  • Review of existing studies on HIV and cardiovascular disease.
  • Analysis of the effects of modern versus older antiretroviral regimens.
  • Investigation of immune activation markers and their correlation with atherosclerosis.

Main Results:

  • Modern ART, when used early and continuously, appears to minimize myocardial infarction risk.
  • Viral suppression and decreased immune activation are key benefits of modern ART regimens.
  • Persistent immune activation in PLWH may contribute to accelerated atherosclerosis and vulnerable coronary lesions.

Conclusions:

  • Early and continuous modern ART is crucial for reducing cardiovascular risk in PLWH.
  • Addressing persistent inflammation through targeted treatments may offer additional cardiovascular protection.
  • Comprehensive management of traditional and non-traditional risk factors is essential for cardiovascular health in PLWH.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
577
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
487
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
314
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
512
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
450